Diadenosines as FHIT-ness instructors

Manuela Campiglio1, Francesca Bianchi, Francesca Andriani

  • 1Department of Experimental Oncology, Molecular Biology Unit, Istituto Nazionale Tumori, Milan, Italy. manuela.campiglio@istitutotumori.mi.it

Insights

The FHIT gene, a tumor suppressor, is often inactivated in human cancers. Its precise oncosuppressive mechanisms and interactions, beyond its known hydrolase activity, are still being explored in cancer research.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Biochemistry

Background:

  • The Fragile Histidine Triad (FHIT) gene functions as a tumor suppressor, frequently inactivated in various human cancers.
  • While Fhit protein's diadenosine triphosphate (Ap3A) hydrolase activity is established, it's not essential for its tumor-suppressive role.
  • The molecular pathways and regulatory elements governing FHIT's oncosuppression remain largely unelucidated.

Purpose of the Study:

  • To review the physiological and pathological roles of FHIT in relation to Ap(n)A signaling molecules.
  • To explore the involvement of FHIT in apoptosis and cell cycle regulation within cancer models.
  • To discuss novel FHIT interactions that may reveal new hypotheses on its biochemical oncosuppressor mechanisms.

Main Methods:

  • Literature review of existing studies on FHIT.
  • Analysis of FHIT's role in Ap(n)A signaling pathways.
  • Examination of FHIT's involvement in apoptosis and cell cycle control.
  • Discussion of recent findings on FHIT protein interactions.

Main Results:

  • FHIT's tumor suppressor function is independent of its Ap3A hydrolase activity.
  • FHIT is implicated in regulating apoptosis and cell cycle progression in cancer.
  • Emerging evidence points to novel protein interactions influencing FHIT's oncosuppressive activity.

Conclusions:

  • The precise biochemical mechanisms of FHIT's tumor suppressor activity are complex and not fully understood.
  • Further research into FHIT's interactions and its role in signaling pathways is crucial for understanding its oncosuppressive function.
  • FHIT remains a significant target for cancer research due to its established role as a tumor suppressor gene.

Related Concept Videos

Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
FISH - Fluorescent In-situ Hybridization02:07

FISH - Fluorescent In-situ Hybridization

Fluorescence in situ hybridization, or FISH, was developed in the early 1980s and has quickly become one of the most widely used techniques in cytogenetics. Labeled probes are used to bind complementary DNA or RNA sequences on a chromosome or in a region within a cell. Earlier, the probes could only be obtained by cloning or reverse transcription of a DNA template. Currently, the probe oligonucleotides can be synthesized synthetically. Additionally, with the advancement of optical techniques,...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...